紫外光固化生物基聚合物市场（按树脂类型、原料、产品形式、应用和最终用途产业划分），全球预测，2026-2032年

2025年，紫外光固化生物基聚合物市场价值为2.7545亿美元，预计2026年将成长至3.151亿美元，复合年增长率为16.14%，到2032年将达到7.8547亿美元。

关键市场统计数据
基准年 2025	2.7545亿美元
预计年份：2026年	3.151亿美元
预测年份 2032	7.8547亿美元
复合年增长率 (%)	16.14%

策略应用：紫外光固化生物基聚合物在光引发性能、可再生原料及产业永续性目标交会点的应用

紫外光固化生物基聚合物的转型，是材料科学创新、永续性需求和不断变化的监管要求三者交汇的产物。本文重点介绍此类材料的核心优势：快速光引发交联、低挥发性有机化合物（VOC）排放，以及整合植物来源和其他生物基单体等可再生原料的潜力。随着涂料、黏合剂、油墨和积层製造（3D列印）等领域的相关人员重新评估其材料选择，紫外光固化生物基材料因其生产效率高、固化能耗低以及潜在的生命週期效益而备受关注。

技术成熟度、监管奖励和采购压力如何共同加速紫外光固化生物基聚合物技术的工业应用

随着材料、製程和政策驱动因素的融合，紫外光固化生物基聚合物的市场格局正在迅速变化，并催生出新的应用路径。光引发剂化学和配方技术的进步，透过提高固化深度、减少泛黄以及增强耐水解性和耐磨性，缩小了紫外光固化生物基聚合物与石油基聚合物之间的性能差距。因此，配方师能够在不影响可再生含量目标的前提下，满足涂料和黏合剂领域日益严格的规格要求。此外，用于积层製造的光敏聚合物的改进，正在拓展其可接受的形状和功能特性范围，使紫外光固化解决方案能够应用于以往仅限于传统热固性材料的终端应用领域。

2025 年贸易措施如何影响紫外光固化生物基聚合物供应链：重组筹资策略、加速在地化生产和促进原料适应性

2025年实施的关税和贸易措施重新强调了生产回流、供应商多元化以及先进製造业关键材料（包括紫外光固化生物基聚合物）供应链韧性的重要性。对某些树脂前驱物和成品组合药物征收的进口关税迫使製造商重新评估筹资策略，并在经济可行的情况下加快本地产能建设。为此，一些下游用户优先签订多供应商供应协议和远期合约以降低关税波动风险，而另一些用户则寻求生物基原料的国内合成路线，以减少对进口中间体的依赖。

基于深度细分的洞察，揭示了应用、产业垂直领域、树脂化学、原料来源和产品形态如何决定技术优先顺序和商业化路径。

细分市场分析揭示了不同应用、终端用户产业、树脂类型、原料和产品形态的需求趋势和发展重点，这些因素共同塑造了紫外光固化生物基聚合物的竞争格局。从应用角度检验，黏合剂、涂料、油墨和3D列印是关键的应用类别。黏合剂包括热熔胶、压敏黏着剂和结构胶。涂料涵盖建筑、汽车、工业和木材应用。油墨包括柔版印刷、喷墨印刷和网版印刷技术。 3D列印包含数位光处理（DLP）、立体光刻技术（SLA）和光固化成型（VPP）方法。每种应用都有其独特的性能、固化和耐久性要求，这迫使配方师优化寡聚物官能度、光引发剂系统和添加剂，以实现所需的应用性能。

区域原材料资源禀赋、监管严格程度以及下游製造群共同塑造了全球采用模式和投资重点。

区域趋势对原料供应、监管驱动因素和客户接受度有显着影响。细緻的区域分析能够辨识出不同地区在产品推广驱动因素和限制因素上的差异。在美洲，健全的农业原料体系和积极的配方改良措施正推动玉米、大豆和蓖麻油基中间体融入供应链。同时，政策奖励和州级永续性目标也为国内生产和试点规模的商业化提供了支持。在欧洲、中东和非洲地区，循环经济指令、生产者延伸责任制以及完善的化学品法规结构正促使製造商检验可再生原料含量并遵守严格的安全和标籤要求，从而影响配方选择和供应商合作。在亚太地区，快速的工业化进程、接近性主要原料产地以及高附加价值製造业的显着增长，正推动着对能够提升永续性指标并满足成本目标的灵活配方的需求。

竞争格局概述，展示了现有企业、专业创新者和供应链伙伴关係关係如何塑造商业化和差异化策略。

开发紫外光固化生物基聚合物的公司之间的竞争格局十分复杂，既包括将配方转向可再生原料的传统化学品製造商，也包括专注于光引发剂和寡聚物设计的技术公司。传统製造商正利用其规模、分销渠道和配方方面的专业知识，将生物基寡聚物整合到现有产品组合中，同时投资建设中先导工厂和认证项目，以证实其可再生成分的宣称。同时，一些敏捷的创新者则凭藉其专有的化学技术脱颖而出，该技术能够匹配生物基单体的多样性，并确保性能的稳定性，从而降低配方师从传统配方转向生物基聚合物的门槛。

为产业领导者提供切实可行的逐步建议，以降低实施风险、保障原料供应并加速商业化，同时采用以客户为中心的检验和供应策略。

产业领导者应采取系统性方法，在管控商业性和技术风险的同时，加速产品推广应用。首先，优先发展可适应多种成分和产品形式的模组化配方平台，以降低供应链波动性，并在关税或物流中断时快速替换。其次，投资于加速检验通讯协定和第三方认证，以检验可再生成分含量和在预期环境压力下的表现。这些认证有助于减少与受监管终端用户和大型原始设备製造商 (OEM) 之间的采购摩擦。第三，与原料加工商和农业合作社建立策略合作伙伴关係，以确保长期供应，并共同开发客製化中间体，在不影响永续性声明的前提下提升产品性能。

为了确保研究结果的可靠性和可操作性，我们采用严格的混合方法调查方法，结合了关键相关人员访谈、标准化实验室检验和文件分析三角验证。

我们的研究途径融合了深度访谈、实验室表现评估和严谨的文献分析，旨在得出切实可行的洞见。深入研究包括与黏合剂、涂料、油墨和积层製造企业的研发经理、采购主管和法规事务专家进行结构化对话，以收集他们在配方挑战和认证时间表方面的实际经验。此外，我们也与原料供应商和加工商进行交流，以了解原料供应、配方要求和区域物流限制。

本书对技术进步、供应链现状以及将紫外光固化生物基聚合物的潜力转化为永续商业性应用所需的策略行动进行了引人入胜的综合分析。

总之，随着树脂化学、光引发剂和加工技术的进步，以及永续性期望和更严格的采购标准的不断提高，紫外光固化生物基聚合物正从实验配方走向可行的工业替代方案。在无需大量资本投入的情况下，能够证明其具有快速固化、低VOC和性能等效等优点，是替代潜力最大的领域。同时，其应用推广将是一个渐进的过程，并受到检验週期、原料物流和监管保障措施的限制，而这些因素会因地区和最终用途而异。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 紫外光固化生物基聚合物市场（依树脂类型划分）

• 丙烯酸酯
  • 双功能
  • 单功能
  • 多功能性
• 环氧树脂
  • 双酚A
  • 双酚F
  • 诺沃拉克
• 杂交种
  • 丙烯酸酯环氧树脂
  • 丙烯酸酯胺甲酸乙酯
• 胺甲酸乙酯
  • 脂肪族
  • 芳香

9. 紫外光固化生物基聚合物市场（依原始材料划分）

• 蓖麻油
• 玉米油
• 亚麻仁油
• 棕榈油
• 大豆油

第十章 紫外光固化生物基聚合物市场（依产品类型划分）

• 电影
• 液体
• 粉末

第十一章 紫外光固化生物基聚合物市场（依应用领域划分）

• 黏合剂
  • 热熔胶
  • 压敏黏着剂
  • 结构
• 画
  • 大楼
  • 车
  • 工业的
  • 木头
• 墨水
  • 柔版印刷
  • 喷墨
  • 网版印刷
• 3D列印
  • 数位立体立体光固成型
  • 立体光刻技术
  • 槽内光聚合

第十二章 紫外光固化生物基聚合物市场（依终端用途产业划分）

• 车
  • 外部的
  • 内部的
  • 机房
• 建筑/施工
  • 地板材料
  • 玻璃
  • 墙
• 电子电器设备
  • 电路基板
  • 涂层和绝缘材料
  • 封装
• 医疗和医疗设备
  • 装置
  • 药品包装
• 包装
  • 灵活的
  • 标籤和油墨
  • 难的

第十三章 区域性紫外光固化生物基聚合物市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 紫外光固化生物基聚合物市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章 各国紫外光固化生物基聚合物市场

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

16. 美国紫外光固化生物基聚合物市场

第十七章：中国紫外光固化生物基聚合物市场

第十八章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Alberdingk Boley GmbH
• Allnex Netherlands BV
• Arkema Group
• BASF SE
• Biome Bioplastics Limited
• Braskem
• Covestro AG
• DIC Corporation
• DRC Resins India
• DSM
• Dymax Corporation
• Eastman Chemical Company
• EcoSynthetix Inc.
• Eternal Materials Co., Ltd.
• Evonik Industries AG
• FKuR Kunststoff GmbH
• hubergroup
• IGM Resins
• Jiangsu Litian Technology Co., Ltd.
• Lambson Limited
• Mitsubishi Chemical Group Corporation
• NatureWorks LLC
• Novamont SpA
• Resonac Holdings Corporation
• Wanhua Chemical Group Co., Ltd

The UV-Curable Bio-Based Polymer Market was valued at USD 275.45 million in 2025 and is projected to grow to USD 315.10 million in 2026, with a CAGR of 16.14%, reaching USD 785.47 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 275.45 million
Estimated Year [2026]	USD 315.10 million
Forecast Year [2032]	USD 785.47 million
CAGR (%)	16.14%

A strategic introduction situating UV-curable bio-based polymers at the nexus of photoinitiated performance, renewable feedstocks, and industrial sustainability ambitions

The transition to UV-curable bio-based polymers represents a confluence of material science innovation, sustainability imperatives, and evolving regulatory expectations. This introduction frames the category by emphasizing its core attributes: rapid photoinitiated crosslinking, low volatile organic compound (VOC) emissions, and the capacity to integrate renewable feedstocks such as vegetable-derived oils and other bio-based monomers. As stakeholders across coatings, adhesives, inks, and additive manufacturing reassess material choices, UV-curable bio-based options are gaining attention for their production efficiency, energy advantages during curing, and potential lifecycle benefits.

Technological progress has broadened the resin palette to include acrylates, epoxies, hybrids, and urethanes adapted for photopolymerization, enabling formulators to balance mechanical performance, chemical resistance, and surface properties with lower reliance on fossil-derived inputs. Concurrently, end-use sectors ranging from automotive interiors to healthcare devices are applying stricter sustainability criteria, driving specifications that prioritize renewables content, reduced emissions, and safer chemistries. Therefore, the introduction situates UV-curable bio-based polymers as an emergent solution at the intersection of performance-driven engineering and greener material strategies.

This section also recognizes persistent industry considerations: the need for validated long-term performance data, compatibility with existing curing equipment, and supply-chain resilience for bio-based feedstocks. It underscores how cross-functional collaboration among R&D, procurement, and regulatory teams will be essential to unlock broader adoption. In sum, the introduction frames the subject as a pragmatic and technically credible pathway toward decarbonization of polymer-based manufacturing while highlighting the operational and commercial levers that will determine speed of uptake.

How technical maturation, regulatory incentives, and procurement pressure are collectively accelerating industrial adoption of UV-curable bio-based polymer technologies

The landscape for UV-curable bio-based polymers has shifted rapidly as material, process, and policy drivers converge to create new trajectories for adoption. Advances in photoinitiator chemistries and formulation approaches have improved cure depths, reduced yellowing, and enhanced resistance to hydrolysis and abrasion, which in turn lowers the performance gap with petrochemical counterparts. As a result, formulators can meet more demanding specifications across coatings and adhesives without sacrificing renewable-content objectives. Moreover, improvements in additive manufacturing photopolymers have expanded allowable geometries and functional properties, making UV-curable solutions viable for end-use cases that were previously constrained to conventional thermosets.

From a process perspective, the emphasis on energy efficiency and speed-to-cure has encouraged manufacturers to retrofit or optimize existing UV curing lines to handle bio-based resins, driven by lifecycle assessments that increasingly favor low-energy curing routes. Regulatory signals and procurement standards have intensified, with public and private buyers including carbon intensity and renewable feedstock criteria in supplier evaluations. These policy and procurement nudges have stimulated greater collaboration across value chains, prompting feedstock suppliers, resin producers, and formulators to develop standardized reporting on biomass content and greenhouse gas implications.

Finally, investor interest and corporate sustainability commitments have generated more funding for scale-up demonstrations and pilot runs, accelerating commercialization of advanced bio-based chemistries. Taken together, these transformative shifts mean the ecosystem is moving from niche demonstrations toward industrial validation, guided by technical maturation, regulatory momentum, and aligned commercial incentives that together make bio-based UV-curable polymers an increasingly practical choice for a range of industrial applications.

How 2025 trade measures reshaped sourcing strategies and accelerated regional production and feedstock adaptation for UV-curable bio-based polymer supply chains

The imposition of tariffs and trade measures in 2025 created renewed emphasis on reshoring, supplier diversification, and supply-chain resilience for materials critical to advanced manufacturing, including UV-curable bio-based polymers. Import duties on certain resin precursors and finished formulations have prompted manufacturers to reassess sourcing strategies and to accelerate local production capabilities where economically feasible. In response, some downstream users prioritized establishing multi-source supply agreements and forward contracts to mitigate exposure to tariff volatility, while others explored domestic synthesis routes for bio-based feedstocks to reduce dependency on imported intermediates.

Tariff-induced cost pressures have also influenced product development priorities. Firms focused on formulations that can utilize regionally abundant feedstocks to minimize cross-border freight and duty impacts. This created opportunities for licensors and technology providers specializing in adaptable chemistries that can accept a range of bio-based oils and monomers. At the same time, companies with integrated supply chains that absorb tariff effects through vertical integration or local manufacturing capacity gained a competitive edge in maintaining price stability for strategic accounts.

Moreover, the trade policy environment has sharpened risk management practices among buyers. Contract clauses now more routinely address duties, and procurement teams conduct scenario analyses to understand near-term cost pass-through and supplier solvency risk. For policy-sensitive sectors such as automotive and medical devices, regulatory compliance and validated provenance of bio-based content became central because tariffs can compound logistical delays that are consequential for tightly scheduled production ramps. In sum, the 2025 tariff landscape acted as a catalyst for greater regionalization, adaptive sourcing, and closer collaboration between resin innovators and feedstock suppliers to safeguard continuity and cost predictability.

Deep segmentation-driven insight revealing how application, industry, resin chemistry, feedstock origin, and product form determine technical priorities and commercialization pathways

Segmentation analysis reveals distinct demand dynamics and development priorities across application, end-use industry, resin type, feedstock, and product form that collectively shape the competitive terrain for UV-curable bio-based polymers. Examining applications shows adhesives, coatings, inks, and three-dimensional printing as the primary use categories, where adhesives include hot melt, pressure-sensitive, and structural formats; coatings cover architectural, automotive, industrial, and wood end-uses; inks span flexographic, inkjet, and screen technologies; and three-dimensional printing encompasses digital light processing, stereolithography, and vat photopolymerization methods. Each application imposes discrete performance, cure, and durability requirements, meaning formulators must optimize oligomer functionality, photoinitiator systems, and additives to achieve application-specific properties.

Looking across end-use industries highlights differentiated adoption pathways. Automotive demand is segmented into exterior, interior, and under-the-hood applications, each with unique thermal, chemical, and aesthetic constraints. Building and construction use cases include flooring, glass, and wall systems where long-term weathering and abrasion resistance are important. Electronics and electrical applications focus on circuit boards, conformal coatings and insulation, and encapsulation for thermal and dielectric stability. Healthcare and medical segments pivot on devices and drug packaging where biocompatibility and sterilization stability are essential. Packaging covers flexible formats, labels and specialty inks, and rigid containers where printability, barrier performance, and recyclability are evaluated.

Resin-type segmentation clarifies material selection trade-offs. Acrylates, epoxies, hybrids, and urethanes each offer different balances of reactivity, toughness, and chemical resistance. Within acrylates, difunctional, monofunctional, and multifunctional variants allow formulators to tune crosslink density; epoxy variants such as bisphenol A, bisphenol F, and novolac provide different thermal and chemical profiles; hybrids like acrylate-epoxy and acrylate-urethane aim to capture hybridized performance benefits; and urethanes, whether aliphatic or aromatic, are selected for weathering and mechanical resilience. Feedstock choices influence the sustainability profile and supply dynamics; castor oil, corn oil, linseed oil, palm oil, and soybean oil provide varying fatty acid profiles that affect oligomer structure and end-use performance.

Product form further dictates handling and process considerations, with film, liquid, and powder forms serving different manufacturing workflows and end-use requirements. Film-form resins may facilitate solventless lamination and coating applications; liquids are broadly used in traditional UV curing and 3D printing platforms; powders enable solvent-free applications with different curing regimes. Integrating these segmentation layers shows that commercial success requires targeted R&D investments and supply agreements tailored to the technical and regulatory constraints of specific applications and industries. Consequently, companies that align resin chemistry choices with feedstock availability and the handling preferences of downstream manufacturers are better positioned to win specification rounds and to scale adoption effectively.

How regional feedstock endowments, regulatory rigor, and downstream manufacturing clusters collectively dictate adoption patterns and investment priorities across the globe

Regional dynamics exert a strong influence on feedstock availability, regulatory drivers, and customer acceptance, and careful regional analysis helps identify where adoption catalysts and constraints differ. In the Americas, robust agricultural feedstock systems and active reformulation efforts favor integration of corn oil, soybean oil, and castor-derived intermediates into supply chains, while policy incentives and state-level sustainability targets encourage both domestic production and pilot-scale commercialization. Meanwhile, in Europe, Middle East & Africa, circularity mandates, extended producer responsibility programs, and established chemical regulatory frameworks push manufacturers to validate renewables content and comply with stringent safety and labeling requirements, which affects formulation choices and supplier partnerships. In Asia-Pacific, rapid industrialization, close proximity to key feedstock producers, and significant additive manufacturing growth spur demand for flexible formulations that can meet cost targets while improving sustainability metrics.

These regional differences also shape investment patterns and collaboration models. Manufacturers in regions with strong downstream clusters tend to co-locate resin development and application testing facilities to accelerate qualification cycles. Conversely, in regions where feedstock logistics are more variable, strategic stockpiling and multi-supplier sourcing strategies are more common. Regulatory stringency and procurement practices influence the pace at which new formulations are validated for critical sectors such as automotive and healthcare. Understanding the interplay between local feedstock endowments, regulatory expectations, and downstream manufacturing capabilities is therefore essential when planning go-to-market strategies and capacity expansions.

Competitive landscape overview showing how incumbents, specialist innovators, and collaborative supply-chain partnerships are shaping commercialization and differentiation strategies

Competitive activity among companies developing UV-curable bio-based polymers spans a spectrum from established chemical manufacturers pivoting formulations toward renewable inputs to specialized technology firms focusing on photoinitiators and oligomer design. Established incumbents leverage scale, distribution networks, and formulary knowledge to integrate bio-based oligomers into existing product families while investing in pilot plants and certification programs to validate renewable content claims. At the same time, nimble innovators are differentiating through proprietary chemistries that reconcile bio-based monomer variability with consistent performance, lowering barriers for formulators to convert legacy recipes.

Collaborative models are increasingly common: joint development agreements between resin producers and downstream formulators accelerate qualification, while partnerships with feedstock suppliers secure access to certified vegetable oil derivatives and modified fatty acids. Investment in analytical capacity, accelerated ageing studies, and standardized test protocols has become a strategic priority so that companies can credibly demonstrate parity or advantages over conventional systems. Additionally, intellectual property around photopolymerizable bio-based oligomers and efficient photoinitiator packages is a key source of competitive advantage, enabling differentiated product claims for speed of cure, adhesion, and long-term durability.

Finally, companies that provide comprehensive customer support-including formulation assistance, on-site application trials, and co-funded qualification projects-tend to shorten sales cycles and build deeper specification-level trust. This customer-centric orientation, combined with targeted R&D and supply security measures, distinguishes market leaders from smaller players and shapes the competitive landscape as adoption moves from pilot projects to commercial-scale use.

Practical, phased recommendations for industry leaders to de-risk adoption, secure feedstocks, and accelerate commercialization with customer-centric validation and supply strategies

Industry leaders should adopt a structured approach to accelerate adoption while managing commercial and technical risk. First, prioritize modular formulation platforms that are adaptable to multiple feedstocks and product forms to mitigate supply-chain variability and to enable quicker substitution when tariffs or logistics disrupt supply. Second, invest in accelerated validation protocols and third-party certifications that verify renewables content and performance across expected environmental stressors; these credentials reduce procurement friction with regulated end-users and large OEMs. Third, pursue strategic alliances with feedstock processors and agricultural cooperatives to secure long-term supply and to co-develop tailored intermediates that enhance performance without undermining sustainability claims.

Leaders should also build internal capabilities for lifecycle assessment and product stewardship, integrating these functions into early-stage product design so that sustainability and compliance are treated as design constraints rather than retrofit tasks. Concurrently, offer customers implementation support including co-development resources, application trials, and training for production teams to ensure smooth transition from petrochemical formulations. Moreover, consider regional manufacturing footprints and flexible contract manufacturing agreements to respond quickly to tariff shifts and local demand surges.

Finally, adopt a phased commercialization strategy that sequences markets by technical tolerance and regulatory appetite. Focus first on applications where performance parity is achievable and approval cycles are shorter, and then extend into more demanding sectors with accumulated performance and regulatory validation. By combining adaptive supply strategies, rigorous validation, and customer-centric implementation, industry leaders can de-risk adoption and capture first-mover advantages in a rapidly evolving landscape.

A rigorous mixed-methods research methodology combining primary stakeholder interviews, standardized lab validation, and document triangulation to ensure credible actionable insights

The research approach integrates primary interviews, lab performance assessments, and rigorous document analysis to produce robust, actionable insights. Primary engagement includes structured discussions with R&D leaders, procurement heads, and regulatory affairs specialists across adhesives, coatings, inks, and additive manufacturing firms to capture lived experience in formulation challenges and qualification timelines. These interviews are complemented by consultations with feedstock suppliers and converters to understand availability, conditioning requirements, and regional logistic constraints.

Lab performance assessments validate comparative properties such as cure speed, crosslink density, adhesion, and environmental resistance under standardized protocols to ensure consistent benchmarking across resin classes. These technical experiments are designed to reflect real-world processing conditions and to identify formulation levers that materially influence end-use performance. Document analysis leverages product technical data sheets, regulatory filings, patent landscapes, and industry standards to triangulate findings and contextualize company-level strategies.

Together, these methods enable synthesis of practical recommendations and risk assessments while ensuring transparency of assumptions. Quality control measures include cross-validation of interview findings with lab results and iterative peer review among subject matter experts to ensure analytical rigor and relevance to decision-makers.

A compelling synthesis of technical progress, supply-chain realities, and strategic actions required to translate UV-curable bio-based polymer potential into sustained commercial adoption

In summary, UV-curable bio-based polymers are transitioning from experimental formulations to viable industrial alternatives as improvements in resin chemistry, photoinitiators, and processing align with heightened sustainability expectations and procurement rigor. The opportunity for substitution is greatest where rapid cure, low VOCs, and performance parity can be demonstrated without major capital expenditure. At the same time, adoption will be incremental and guided by validation cycles, feedstock logistics, and regulatory safeguards that vary by region and end-use application.

Companies that succeed will be those that combine adaptive formulation platforms with secured feedstock agreements, robust validation data, and customer-focused implementation support. Strategic partnerships and targeted regional investments will shorten qualification timelines and reduce exposure to trade volatility. Ultimately, the pathway to scaling bio-based UV-curable solutions is as much organizational and logistical as it is technical, requiring aligned teams across R&D, supply management, and commercial functions to translate technical promise into commercial reality.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. UV-Curable Bio-Based Polymer Market, by Resin Type

• 8.1. Acrylate
  • 8.1.1. Difunctional
  • 8.1.2. Monofunctional
  • 8.1.3. Multifunctional
• 8.2. Epoxy
  • 8.2.1. Bisphenol A
  • 8.2.2. Bisphenol F
  • 8.2.3. Novolac
• 8.3. Hybrid
  • 8.3.1. Acrylate Epoxy
  • 8.3.2. Acrylate Urethane
• 8.4. Urethane
  • 8.4.1. Aliphatic
  • 8.4.2. Aromatic

9. UV-Curable Bio-Based Polymer Market, by Feedstock

• 9.1. Castor Oil
• 9.2. Corn Oil
• 9.3. Linseed Oil
• 9.4. Palm Oil
• 9.5. Soybean Oil

10. UV-Curable Bio-Based Polymer Market, by Product Form

• 10.1. Film
• 10.2. Liquid
• 10.3. Powder

11. UV-Curable Bio-Based Polymer Market, by Application

• 11.1. Adhesives
  • 11.1.1. Hot Melt
  • 11.1.2. Pressure Sensitive
  • 11.1.3. Structural
• 11.2. Coatings
  • 11.2.1. Architectural
  • 11.2.2. Automotive
  • 11.2.3. Industrial
  • 11.2.4. Wood
• 11.3. Inks
  • 11.3.1. Flexographic
  • 11.3.2. Inkjet
  • 11.3.3. Screen
• 11.4. Three D Printing
  • 11.4.1. Digital Light Processing
  • 11.4.2. Stereolithography
  • 11.4.3. Vat Photopolymerization

12. UV-Curable Bio-Based Polymer Market, by End Use Industry

• 12.1. Automotive
  • 12.1.1. Exteriors
  • 12.1.2. Interiors
  • 12.1.3. Under The Hood
• 12.2. Building & Construction
  • 12.2.1. Flooring
  • 12.2.2. Glass
  • 12.2.3. Wall
• 12.3. Electronics & Electrical
  • 12.3.1. Circuit Boards
  • 12.3.2. Coating & Insulation
  • 12.3.3. Encapsulation
• 12.4. Healthcare & Medical
  • 12.4.1. Devices
  • 12.4.2. Drug Packaging
• 12.5. Packaging
  • 12.5.1. Flexible
  • 12.5.2. Labels & Inks
  • 12.5.3. Rigid

13. UV-Curable Bio-Based Polymer Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. UV-Curable Bio-Based Polymer Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. UV-Curable Bio-Based Polymer Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. United States UV-Curable Bio-Based Polymer Market

17. China UV-Curable Bio-Based Polymer Market

18. Competitive Landscape

• 18.1. Market Concentration Analysis, 2025
  • 18.1.1. Concentration Ratio (CR)
  • 18.1.2. Herfindahl Hirschman Index (HHI)
• 18.2. Recent Developments & Impact Analysis, 2025
• 18.3. Product Portfolio Analysis, 2025
• 18.4. Benchmarking Analysis, 2025
• 18.5. Alberdingk Boley GmbH
• 18.6. Allnex Netherlands B.V.
• 18.7. Arkema Group
• 18.8. BASF SE
• 18.9. Biome Bioplastics Limited
• 18.10. Braskem
• 18.11. Covestro AG
• 18.12. DIC Corporation
• 18.13. DRC Resins India
• 18.14. DSM
• 18.15. Dymax Corporation
• 18.16. Eastman Chemical Company
• 18.17. EcoSynthetix Inc.
• 18.18. Eternal Materials Co., Ltd.
• 18.19. Evonik Industries AG
• 18.20. FKuR Kunststoff GmbH
• 18.21. hubergroup
• 18.22. IGM Resins
• 18.23. Jiangsu Litian Technology Co., Ltd.
• 18.24. Lambson Limited
• 18.25. Mitsubishi Chemical Group Corporation
• 18.26. NatureWorks LLC
• 18.27. Novamont S.p.A.
• 18.28. Resonac Holdings Corporation
• 18.29. Wanhua Chemical Group Co., Ltd

LIST OF FIGURES

• FIGURE 1. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RESIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FEEDSTOCK, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRODUCT FORM, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. UNITED STATES UV-CURABLE BIO-BASED POLYMER MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 13. CHINA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DIFUNCTIONAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DIFUNCTIONAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DIFUNCTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY MONOFUNCTIONAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY MONOFUNCTIONAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY MONOFUNCTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY MULTIFUNCTIONAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY MULTIFUNCTIONAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY MULTIFUNCTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BISPHENOL A, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BISPHENOL A, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BISPHENOL A, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BISPHENOL F, BY REGION, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BISPHENOL F, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BISPHENOL F, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY NOVOLAC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY NOVOLAC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY NOVOLAC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE EPOXY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE EPOXY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE EPOXY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE URETHANE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE URETHANE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE URETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ALIPHATIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ALIPHATIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ALIPHATIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AROMATIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AROMATIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AROMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FEEDSTOCK, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CASTOR OIL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CASTOR OIL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CASTOR OIL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CORN OIL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CORN OIL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CORN OIL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LINSEED OIL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LINSEED OIL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LINSEED OIL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PALM OIL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PALM OIL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PALM OIL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY SOYBEAN OIL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY SOYBEAN OIL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY SOYBEAN OIL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FILM, BY REGION, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FILM, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FILM, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HOT MELT, BY REGION, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HOT MELT, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 82. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HOT MELT, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRESSURE SENSITIVE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 84. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRESSURE SENSITIVE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 85. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRESSURE SENSITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 86. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY STRUCTURAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 87. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY STRUCTURAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 88. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY STRUCTURAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 89. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 90. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 91. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 92. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
• TABLE 93. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ARCHITECTURAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 94. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ARCHITECTURAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 95. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ARCHITECTURAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 96. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 97. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 98. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 99. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 100. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 101. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 102. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY WOOD, BY REGION, 2018-2032 (USD MILLION)
• TABLE 103. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY WOOD, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 104. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY WOOD, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 105. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 106. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 107. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 108. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, 2018-2032 (USD MILLION)
• TABLE 109. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLEXOGRAPHIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 110. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLEXOGRAPHIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 111. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLEXOGRAPHIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 112. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKJET, BY REGION, 2018-2032 (USD MILLION)
• TABLE 113. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKJET, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 114. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKJET, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 115. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY SCREEN, BY REGION, 2018-2032 (USD MILLION)
• TABLE 116. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY SCREEN, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 117. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY SCREEN, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 118. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 119. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 120. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 121. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, 2018-2032 (USD MILLION)
• TABLE 122. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DIGITAL LIGHT PROCESSING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 123. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DIGITAL LIGHT PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 124. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DIGITAL LIGHT PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 125. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY STEREOLITHOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 126. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY STEREOLITHOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 127. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY STEREOLITHOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 128. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY VAT PHOTOPOLYMERIZATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 129. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY VAT PHOTOPOLYMERIZATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 130. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY VAT PHOTOPOLYMERIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 131. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
• TABLE 132. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 133. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 134. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 135. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
• TABLE 136. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EXTERIORS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 137. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EXTERIORS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 138. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EXTERIORS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 139. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INTERIORS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 140. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INTERIORS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 141. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INTERIORS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 142. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY UNDER THE HOOD, BY REGION, 2018-2032 (USD MILLION)
• TABLE 143. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY UNDER THE HOOD, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 144. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY UNDER THE HOOD, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 145. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 146. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 147. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 148. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 149. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLOORING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 150. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLOORING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 151. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLOORING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 152. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 153. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 154. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 155. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY WALL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 156. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY WALL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 157. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY WALL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 158. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 159. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 160. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 161. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, 2018-2032 (USD MILLION)
• TABLE 162. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CIRCUIT BOARDS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 163. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CIRCUIT BOARDS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 164. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY CIRCUIT BOARDS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 165. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATING & INSULATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 166. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATING & INSULATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 167. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATING & INSULATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 168. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ENCAPSULATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 169. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ENCAPSULATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 170. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ENCAPSULATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 171. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 172. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 173. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 174. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2032 (USD MILLION)
• TABLE 175. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DEVICES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 176. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 177. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 178. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DRUG PACKAGING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 179. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DRUG PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 180. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY DRUG PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 181. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 182. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 183. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 184. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
• TABLE 185. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 186. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 187. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 188. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LABELS & INKS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 189. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LABELS & INKS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 190. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY LABELS & INKS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 191. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
• TABLE 192. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 193. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 194. GLOBAL UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 195. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 196. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
• TABLE 197. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, 2018-2032 (USD MILLION)
• TABLE 198. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
• TABLE 199. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, 2018-2032 (USD MILLION)
• TABLE 200. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, 2018-2032 (USD MILLION)
• TABLE 201. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FEEDSTOCK, 2018-2032 (USD MILLION)
• TABLE 202. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
• TABLE 203. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 204. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, 2018-2032 (USD MILLION)
• TABLE 205. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
• TABLE 206. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, 2018-2032 (USD MILLION)
• TABLE 207. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, 2018-2032 (USD MILLION)
• TABLE 208. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
• TABLE 209. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
• TABLE 210. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 211. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, 2018-2032 (USD MILLION)
• TABLE 212. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2032 (USD MILLION)
• TABLE 213. AMERICAS UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
• TABLE 214. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 215. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
• TABLE 216. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, 2018-2032 (USD MILLION)
• TABLE 217. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
• TABLE 218. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, 2018-2032 (USD MILLION)
• TABLE 219. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, 2018-2032 (USD MILLION)
• TABLE 220. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FEEDSTOCK, 2018-2032 (USD MILLION)
• TABLE 221. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
• TABLE 222. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 223. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, 2018-2032 (USD MILLION)
• TABLE 224. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
• TABLE 225. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, 2018-2032 (USD MILLION)
• TABLE 226. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, 2018-2032 (USD MILLION)
• TABLE 227. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
• TABLE 228. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
• TABLE 229. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 230. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, 2018-2032 (USD MILLION)
• TABLE 231. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2032 (USD MILLION)
• TABLE 232. NORTH AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
• TABLE 233. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 234. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
• TABLE 235. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, 2018-2032 (USD MILLION)
• TABLE 236. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
• TABLE 237. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, 2018-2032 (USD MILLION)
• TABLE 238. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, 2018-2032 (USD MILLION)
• TABLE 239. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FEEDSTOCK, 2018-2032 (USD MILLION)
• TABLE 240. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
• TABLE 241. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 242. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, 2018-2032 (USD MILLION)
• TABLE 243. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
• TABLE 244. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, 2018-2032 (USD MILLION)
• TABLE 245. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, 2018-2032 (USD MILLION)
• TABLE 246. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
• TABLE 247. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
• TABLE 248. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 249. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, 2018-2032 (USD MILLION)
• TABLE 250. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2032 (USD MILLION)
• TABLE 251. LATIN AMERICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, 2018-2032 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, 2018-2032 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, 2018-2032 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FEEDSTOCK, 2018-2032 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, 2018-2032 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, 2018-2032 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, 2018-2032 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, 2018-2032 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2032 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
• TABLE 271. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 272. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
• TABLE 273. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, 2018-2032 (USD MILLION)
• TABLE 274. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
• TABLE 275. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, 2018-2032 (USD MILLION)
• TABLE 276. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, 2018-2032 (USD MILLION)
• TABLE 277. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FEEDSTOCK, 2018-2032 (USD MILLION)
• TABLE 278. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
• TABLE 279. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 280. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, 2018-2032 (USD MILLION)
• TABLE 281. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
• TABLE 282. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, 2018-2032 (USD MILLION)
• TABLE 283. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, 2018-2032 (USD MILLION)
• TABLE 284. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
• TABLE 285. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
• TABLE 286. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY BUILDING & CONSTRUCTION, 2018-2032 (USD MILLION)
• TABLE 287. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ELECTRONICS & ELECTRICAL, 2018-2032 (USD MILLION)
• TABLE 288. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2032 (USD MILLION)
• TABLE 289. EUROPE UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
• TABLE 290. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 291. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
• TABLE 292. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ACRYLATE, 2018-2032 (USD MILLION)
• TABLE 293. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
• TABLE 294. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY HYBRID, 2018-2032 (USD MILLION)
• TABLE 295. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY URETHANE, 2018-2032 (USD MILLION)
• TABLE 296. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY FEEDSTOCK, 2018-2032 (USD MILLION)
• TABLE 297. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY PRODUCT FORM, 2018-2032 (USD MILLION)
• TABLE 298. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 299. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY ADHESIVES, 2018-2032 (USD MILLION)
• TABLE 300. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY COATINGS, 2018-2032 (USD MILLION)
• TABLE 301. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY INKS, 2018-2032 (USD MILLION)
• TABLE 302. MIDDLE EAST UV-CURABLE BIO-BASED POLYMER MARKET SIZE, BY THREE D PRINTING, 2018-2032